Literature DB >> 8403524

Duodenal intraepithelial gamma/delta T cells and soluble CD8, neopterin, and beta 2-microglobulin in serum of IgA-deficient subjects with or without IgG subclass deficiency.

D E Nilssen1, P Aukrust, S S Frøland, F Müller, O Fausa, T S Halstensen, P Brandtzaeg.   

Abstract

Expression of the gamma/delta T cell receptor (TCR) on CD3+ intraepithelial lymphocytes (IELs) was studied by two-colour immunofluorescence in duodenal tissue sections from healthy (n = 6) or infection-prone (n = 7) subjects with selective IgA deficiency (IgAD), and subjects (n = 4) with combined IgAD and IgG subclass deficiency. TCR gamma/delta+ IEL proportions in selective IgAD subjects (median 6.3%, range 1.0-41%) and in those with combined deficiency (median 4.5%, range 1.2-33%) were well within the range (0.3-38%) for histologically normal controls (n = 11), but the healthy IgAD subgroup tended to show raised TCR gamma/delta+ IEL proportions (median 13.6%) compared with the other two subgroups. Also the number of TCR gamma/delta+ IELs per intestinal length unit was relatively high (median 13.9/mm) in the healthy IgAD subjects, and significantly raised (P < 0.03) compared with controls (median 3.2/mm). Paired staining revealed that most TCR gamma/delta+ IELs in both selective IgAD (98%) and combined deficiency (99%) were CD8-, and a large fraction (median 84% and 63%, respectively) expressed the V delta 1/J delta 1-encoded epitope. The total number of CD3+ IELs (mostly CD8+) was similar to controls. IgAD subjects, and especially the healthy subgroup, had significantly increased serum concentrations of soluble CD8 (P < 0.0002), neopterin (P < 0.005), and beta 2-microglobulin (P < 0.007), which was similar to our previous observations in common variable immunodeficiency, and probably reflected stimulation of cell-mediated immunity. In addition, the increased TCR gamma/delta+ IELs might reflect a component of compensatory surface protection in the healthy IgAD subgroup.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8403524      PMCID: PMC1534359          DOI: 10.1111/j.1365-2249.1993.tb05983.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  40 in total

1.  Increase of lymphocytes bearing the gamma/delta T cell receptor in the jejunum of patients with dermatitis herpetiformis.

Authors:  E Savilahti; T Reunala; M Mäki
Journal:  Gut       Date:  1992-02       Impact factor: 23.059

2.  Various keratin antibodies produce immunohistochemical staining of human myocardium and myometrium.

Authors:  H S Huitfeldt; P Brandtzaeg
Journal:  Histochemistry       Date:  1985

Review 3.  Humoral immune response patterns of human mucosae: induction and relation to bacterial respiratory tract infections.

Authors:  P Brandtzaeg
Journal:  J Infect Dis       Date:  1992-06       Impact factor: 5.226

4.  Mucosal and glandular distribution of immunoglobulin components. Immunohistochemistry with a cold ethanol-fixation technique.

Authors:  P Brandtzaeg
Journal:  Immunology       Date:  1974-06       Impact factor: 7.397

5.  Abnormally high concentrations of beta 2 microglobulin in acquired immunodeficiency syndrome (AIDS) patients.

Authors:  R B Bhalla; B Safai; R Mertelsmann; M K Schwartz
Journal:  Clin Chem       Date:  1983-08       Impact factor: 8.327

6.  Raised serum neopterin levels in patients with primary hypogammaglobulinaemia; correlation to other immunological parameters and to clinical and histological features.

Authors:  P Aukrust; S S Frøland; F Müller
Journal:  Clin Exp Immunol       Date:  1992-08       Impact factor: 4.330

7.  Intestinal salivary, and tonsillar IgA and J-chain production in a patient with severe deficiency of serum IgA.

Authors:  P Brandtzaeg; D Guy-Grand; C Griscelli
Journal:  Scand J Immunol       Date:  1981       Impact factor: 3.487

8.  Subclass composition and J-chain expression of the 'compensatory' gastrointestinal IgG cell population in selective IgA deficiency.

Authors:  D E Nilssen; P Brandtzaeg; S S Frøland; O Fausa
Journal:  Clin Exp Immunol       Date:  1992-02       Impact factor: 4.330

9.  Lymphocyte subpopulations in the human small intestine. The findings in normal mucosa and in the mucosa of patients with adult coeliac disease.

Authors:  W S Selby; G Janossy; M Bofill; D P Jewell
Journal:  Clin Exp Immunol       Date:  1983-04       Impact factor: 4.330

10.  Clinical findings and intestinal immunoglobulins in children with partial IgA deficiency.

Authors:  E Savilahti; P Pelkonen
Journal:  Acta Paediatr Scand       Date:  1979-07
View more
  6 in total

1.  Intraepithelial gamma/delta T cells in duodenal mucosa are related to the immune state and survival time in AIDS.

Authors:  D E Nilssen; F Müller; O Oktedalen; S S Frøland; O Fausa; T S Halstensen; P Brandtzaeg
Journal:  J Virol       Date:  1996-06       Impact factor: 5.103

2.  Intestinal B cell hyperactivity in AIDS is controlled by highly active antiretroviral therapy.

Authors:  D E Nilssen; O Øktedalen; P Brandtzaeg
Journal:  Gut       Date:  2004-04       Impact factor: 23.059

3.  Immunohistochemical findings in jejunal specimens from patients with IgA deficiency.

Authors:  T Klemola; E Savilahti; A Arato; T Ormälä; J Partanen; C Eland; S Koskimies
Journal:  Gut       Date:  1995-10       Impact factor: 23.059

4.  High density of intraepithelial gammadelta lymphocytes and deposits of immunoglobulin (Ig)M anti-tissue transglutaminase antibodies in the jejunum of coeliac patients with IgA deficiency.

Authors:  M Borrelli; M Maglio; M Agnese; F Paparo; S Gentile; B Colicchio; A Tosco; R Auricchio; R Troncone
Journal:  Clin Exp Immunol       Date:  2009-12-21       Impact factor: 4.330

5.  Age-related variation of intraepithelial lymphocytes subsets in normal human duodenal mucosa.

Authors:  Cristina Camarero; Francisco Leon; Laura Sanchez; Angel Asensio; Garbiñe Roy
Journal:  Dig Dis Sci       Date:  2007-03       Impact factor: 3.487

6.  Intraepithelial γδ T cells remain increased in the duodenum of AIDS patients despite antiretroviral treatment.

Authors:  Dag E Nilssen; Per Brandtzaeg
Journal:  PLoS One       Date:  2012-01-04       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.